Hemophilia

Hemophilia A is a genetic deficiency in clotting factor VIII, which causes increased bleeding and usually affects males. About 70% of the time it is inherited as an X-linked recessive trait, but around 30% of cases arise from spontaneous mutations. Hemophilia B  is a blood clotting disorder caused by a mutation of the factor IX gene, leading to a deficiency of factor IX. It is the second-most common form of haemophilia, rarer than haemophilia A. It is sometimes called Christmas disease, named after Stephen Christmas, the first patient described with this disease. In addition, the first report of its identification was published in the Christmas edition of the British Medical Journal. Hemophilia C  is a mild form of haemophilia affecting both sexes. Acquired Hemophilia is fourth type of hemophilia and is rarest among all "Acquired” means you aren't born with the disorder, but you develop it during your lifetime. This can happen if your body forms antibodies that attack the clotting factors in your bloodstream. The antibodies can prevent the clotting factors from working.

Related conference: 3rd International Conference on Hematology & Blood Disorders November 02-04, 2015 USA; 6th International Conference on Hematology & Lymph November 14-16, 2016, USA;4th International Conference on Blood Malignancies and Treatment April 18-20, 2016, UAE; International Conference on Leukemia and Bone marrow Transplantation November 10-12, 2016 Turkey ; 7th Health Care and Fitness Summit September 26-28, 2016, UK ;NHF's 67th Annual Meeting, Dallas, August 13-15, 2015 USA; European Hemophilia Consortium (EHC) Conference, 02-04 October 2015, Serbia; Hemophilia & Thrombosis Research Society (HTRS) Scientific Symposium, 25-26 November 2015, USA ; Society of Thrombosis and Haemostasis Research (GTH) Annual Meeting1 7- 20 Feb 2016, Germany ; American Society of Hematology (ASH) Annual Meeting & Exposition December 5-8, 2015 USA

Hemophilia, is a group of hereditary genetic disorders that impair the body's ability to controlblood clotting, which is used to stop bleeding when a blood vessel is broken. Like other recessive sex-linked, X chromosome disorders, haemophilia is more likely to occur in males than females. People with haemophilia have lower clotting factor level of blood plasma or impaired activity of the coagulation factors needed for a normal clotting process. According to the US Centers for Disease Control and Prevention, hemophilia occurs in approximately 1 in 5,000 live births. There are about 20,000 people with hemophilia in the US. 

  • Hemophilia A
  • Hemophilia B
  • Hemophilia C
  • Acquired hemophilia
  • Coagulation factors deficiency

Related Conference of Hemophilia

Hemophilia Conference Speakers